Free Trial

Versor Investments LP Cuts Position in Mettler-Toledo International Inc. (NYSE:MTD)

Mettler-Toledo International logo with Medical background
Remove Ads

Versor Investments LP trimmed its position in shares of Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 69.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 362 shares of the medical instruments supplier's stock after selling 808 shares during the period. Versor Investments LP's holdings in Mettler-Toledo International were worth $443,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in the company. State Street Corp increased its stake in shares of Mettler-Toledo International by 1.0% during the third quarter. State Street Corp now owns 954,653 shares of the medical instruments supplier's stock worth $1,431,693,000 after buying an additional 9,009 shares during the period. Geode Capital Management LLC increased its stake in shares of Mettler-Toledo International by 0.8% during the third quarter. Geode Capital Management LLC now owns 547,439 shares of the medical instruments supplier's stock worth $818,906,000 after buying an additional 4,166 shares during the period. Principal Financial Group Inc. increased its stake in shares of Mettler-Toledo International by 13.9% during the fourth quarter. Principal Financial Group Inc. now owns 274,563 shares of the medical instruments supplier's stock worth $335,977,000 after buying an additional 33,456 shares during the period. Barclays PLC increased its stake in shares of Mettler-Toledo International by 8.3% during the third quarter. Barclays PLC now owns 256,602 shares of the medical instruments supplier's stock worth $384,822,000 after buying an additional 19,609 shares during the period. Finally, JPMorgan Chase & Co. increased its stake in shares of Mettler-Toledo International by 14.7% during the third quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier's stock worth $332,634,000 after buying an additional 28,478 shares during the period. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on MTD shares. Wolfe Research started coverage on Mettler-Toledo International in a report on Friday, December 13th. They issued a "peer perform" rating for the company. Robert W. Baird upped their price target on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the company a "neutral" rating in a report on Monday, February 10th. Evercore ISI upped their price target on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an "outperform" rating in a report on Monday, February 10th. Citigroup lowered their price target on Mettler-Toledo International from $1,450.00 to $1,400.00 and set a "neutral" rating for the company in a report on Tuesday. Finally, Wells Fargo & Company upped their price target on Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the company an "equal weight" rating in a report on Monday, February 10th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $1,380.50.

View Our Latest Analysis on MTD

Mettler-Toledo International Price Performance

Shares of MTD stock traded up $4.15 during trading hours on Thursday, hitting $1,261.99. The stock had a trading volume of 71,489 shares, compared to its average volume of 137,373. The firm has a market capitalization of $26.40 billion, a PE ratio of 31.21, a PEG ratio of 3.30 and a beta of 1.13. Mettler-Toledo International Inc. has a twelve month low of $1,142.91 and a twelve month high of $1,546.93. The stock's 50 day moving average is $1,292.06 and its 200 day moving average is $1,326.21.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last posted its quarterly earnings data on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share for the quarter, beating the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. As a group, equities analysts predict that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current year.

Insider Transactions at Mettler-Toledo International

In other news, insider Gerry Keller sold 600 shares of the company's stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total transaction of $810,804.00. Following the completion of the sale, the insider now owns 6 shares in the company, valued at $8,108.04. This represents a 99.01 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Christian Magloth sold 790 shares of the company's stock in a transaction that occurred on Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the sale, the insider now owns 734 shares of the company's stock, valued at $964,248.46. This trade represents a 51.84 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.94% of the company's stock.

About Mettler-Toledo International

(Free Report)

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Read More

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Should You Invest $1,000 in Mettler-Toledo International Right Now?

Before you consider Mettler-Toledo International, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mettler-Toledo International wasn't on the list.

While Mettler-Toledo International currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Will Tesla’s Robot Future Save Its Falling Stock?
NVIDIA’s Dip Is a Gift—Here’s Why It Won’t Last
Best ETFs for Spring 2025: Strong and Steady Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads